Apex Biotechnology Corp. · TWSE:1733
Apex Biotechnology — Investor Conference (November 2023)
16 slides from Apex Biotechnology's conference presentation, November 2023
Slide 1: ApexBio Taiwan Investor Conference Nov 2023
Be $ 2k APEXBIO aiwan Nov 2023
Slide 2: Company profile
Company profile TSEC 1733 Industry IVD Medical Device Operation Locations .Head quarter: No. 7, Li-Hsin 5th Rd., Hsinchu Science Park, Hsinchu, Taiwan .Tao Yuan Factory: No. 180, Lane 70, Wuqing Rd., Dayuan Dist., Taoyuan City, Taiwan .Suzhou Corp.: Room 106, No.2, Kecheng Road, SIP, Suzhou, China .
Slide 3: Milestone
Milestone 1997-2001 2002-2006 2007-2011 1997 ApexBio set-up 2002 ISO 9001/13485 notified 2007 Lactate launch 1998 BGM FDA 510K approval 2003 CE IVDD notified 2008 oice BGM launch 1999 Uric Acid patent granted 2005 Pesticide residues check 2009 Taoyuan factory set-up 2000 IPO listed to Taiwan OTC pro
Slide 4: Quality System
Quality System Region The Authority Regulatory compliance Taiwan TFDA QMS ISO 13485:2016 EU CE CE mark number:CE0197 EN ISO 15197:2015 Quality System Regulation (21CFR Part 820) USA FDA 510K’s FDA on-site audit w/o 483 citations China NMPA Medical Device Class II Brazil ANVISA 2017 passed on-site au
Slide 5: Product profile
Product profile Blood glucose monitoring systems Professional Monitoring systems ◼ Uric Acid ◼ Hemoglobin ◼ Lactate ◼ Ketone 5
Slide 6: Multi-functional systems and Eclipse PLUS
Multi-functional systems ◼ Glucose + Ketone ◼ Glucose + Cholesterol + TG + Uric Acid Eclipse PLUS For Clinic and Hospital Pre-screening Diabetic Kidney Disease • HbA1c • Microalbumin • Creatinine • ACR 6
Slide 7: GLUCOSURE POC
Ketone POC barcode scanner + Wi-Fi Hospital GLUCOSURE POC Glucose/Ketone POC barcode scanner + Wi-Fi 7
Slide 8: Hemoglobin and Blood Lactate Monitoring Systems
Hemoglobin Monitoring System Blood Lactate Monitoring System 7
Slide 9: 8-in-1 Point of Care Monitoring System
8-in-1 Point of Care Monitoring System ◼Blood Glucose ◼Uric Acid ◼Cholesterol & LDL ◼Hemoglobin ◼Lactate ◼Ketone ◼Creatinine ◼Triglycerides 7
Slide 10: New pipeline products
New pipeline products ◼ Rapid test TFDA QMS passed Developing items: • COVID-19 Antigen Rapid Test Kit • Influenza Rapid Test Kit • Vector-borne Disease Detection for Mosquito-borne Illnesses • Economic Animal and Animal Epidemic Prevention Detection • DOA ◼ Home use CGM
Slide 11: Customized projects
Customized projects ◼ Product platform focus on electrochemistry/photometry/ Lateral flow assay , to derive new parameter tests and optimize our core platform. ◼ Sharing our advantage of regulation/quality control/sales channels/clinical trails/manufacturing to alliance with partners and customers.
Slide 12: Global sales distribution
Global sales distribution Territory 2021 2022 2023/1-3Q America 43% 40% 39.3% EU 45% 49% 46.5% Asia 11% 10% 12.6% Africa 1% 1% 1.6%
Slide 13: Finance Performance
Finance Performance Year 2021 2022 2023/1-3Q Revenue 2,131,656 2,244,176 1,266,309 Gross margin 571,512 576,839 394,519 Operation profit 204,949 176,560 103,384 Profit after tax 202,289 181,451 100,664 EPS 2.03 1.82 1.01 G/M ratio 27% 26% 31% Shipped Meter Qty (kit) 1,677K 1,821K 868K Shipped Strip
Slide 14: Product ratio
Product ratio 2022 2023/1-3Q BGM & A1C Electrode BGM & A1C Electrode Non-BGM Others Non-BGM Others 3% 5% 14% 13% 13% 16% 70% 66% Non-BGM Hemoglobin/Ketone/Uric Acid/Lactate/Cholesterol/ Pesticide quick check etc.
Slide 15: The 9th Corporate Governance Evaluation (2022)
the 9th Corporate Governance Evaluation (2022) Number of Points for Total number inapplicable Extra Credit Category satisfied of indicators indicators Indicators: indicators Year 2021 2022 2021 2022 2021 2022 2021 2022 Protecting Shareholder Rights and Interests and Treating 16 16 15 13 0 0 0 1 Shar
Slide 16: Thank you
Thank you
Apex Biotechnology — Investor Conference (November 2023) on 6ix